JP2007512387A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007512387A5 JP2007512387A5 JP2006542002A JP2006542002A JP2007512387A5 JP 2007512387 A5 JP2007512387 A5 JP 2007512387A5 JP 2006542002 A JP2006542002 A JP 2006542002A JP 2006542002 A JP2006542002 A JP 2006542002A JP 2007512387 A5 JP2007512387 A5 JP 2007512387A5
- Authority
- JP
- Japan
- Prior art keywords
- carbon atoms
- caprolactam
- amino
- pharmaceutically acceptable
- dimethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0327775.3 | 2003-12-01 | ||
| GB0327775A GB0327775D0 (en) | 2003-12-01 | 2003-12-01 | Anti-inflammatory agents |
| GB0417436.3 | 2004-08-05 | ||
| GB0417436A GB0417436D0 (en) | 2004-08-05 | 2004-08-05 | Anti-inflammatory agents |
| GB0417734.1 | 2004-08-10 | ||
| GB0417734A GB0417734D0 (en) | 2004-08-10 | 2004-08-10 | Anti-Inflammatory agents |
| PCT/GB2004/005030 WO2005053702A2 (en) | 2003-12-01 | 2004-11-30 | Anti-inflammatory agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007512387A JP2007512387A (ja) | 2007-05-17 |
| JP2007512387A5 true JP2007512387A5 (enExample) | 2008-03-21 |
| JP5248779B2 JP5248779B2 (ja) | 2013-07-31 |
Family
ID=34657584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006542002A Expired - Lifetime JP5248779B2 (ja) | 2003-12-01 | 2004-11-30 | 抗炎症剤 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20080227724A1 (enExample) |
| EP (2) | EP2279741A3 (enExample) |
| JP (1) | JP5248779B2 (enExample) |
| KR (1) | KR101228268B1 (enExample) |
| CN (1) | CN103393691A (enExample) |
| AR (1) | AR047730A1 (enExample) |
| CA (1) | CA2547651C (enExample) |
| CY (1) | CY1113171T1 (enExample) |
| DK (1) | DK1691814T3 (enExample) |
| ES (1) | ES2390272T3 (enExample) |
| IL (1) | IL175857A0 (enExample) |
| PL (1) | PL1691814T3 (enExample) |
| PT (1) | PT1691814E (enExample) |
| SI (1) | SI1691814T1 (enExample) |
| TW (1) | TWI356821B (enExample) |
| WO (1) | WO2005053702A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2418426A (en) | 2004-08-18 | 2006-03-29 | Univ Cambridge Tech | Alpha-(acylamino)-bicyclolactam derivatives for treatment of inflammatory disorders |
| GB2418427A (en) * | 2004-09-02 | 2006-03-29 | Univ Cambridge Tech | Ligands for G-protein coupled receptors |
| AU2011226837B2 (en) * | 2004-09-02 | 2014-09-18 | Cambridge Enterprise Limited | Ligands for G-protein coupled receptors |
| GB0512238D0 (en) * | 2005-06-15 | 2005-07-27 | Univ Cambridge Tech | Anti-inflammatory agents |
| US7662967B2 (en) | 2007-08-02 | 2010-02-16 | Cambridge Enterprise Limited | Anti-inflammatory compounds and compositions |
| GB2452696B (en) | 2007-08-02 | 2009-09-23 | Cambridge Entpr Ltd | 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions |
| GB2455539B (en) * | 2007-12-12 | 2012-01-18 | Cambridge Entpr Ltd | Anti-inflammatory compositions and combinations |
| GB201009603D0 (en) * | 2010-06-08 | 2010-07-21 | Cambridge Entpr Ltd | Anti-inflammatory agent |
| JP6173352B2 (ja) * | 2012-02-15 | 2017-08-02 | アニダ ファーマ インコーポレイテッド | 筋萎縮性側索硬化症の治療方法 |
| CA3050572A1 (en) * | 2017-01-18 | 2018-07-26 | Universitat Autonoma De Barcelona | Specialized pro-resolving lipid mediators for use in the treatment of neurodegenerative diseases and/or autoimmune diseases |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB327775A (en) | 1929-01-21 | 1930-04-17 | John Harry Grayson | Improvements in thermostats |
| NL37108C (enExample) | 1933-06-02 | |||
| US3754026A (en) * | 1969-10-17 | 1973-08-21 | Allied Chem | Fluorocarbon amides |
| JPS53121781A (en) * | 1977-03-30 | 1978-10-24 | Torii Yakuhin Kk | Caprolactum derivatives |
| JPS625994A (ja) * | 1985-07-02 | 1987-01-12 | Toray Ind Inc | リジン誘導体の製造法 |
| EP0312157A3 (en) * | 1987-10-13 | 1990-07-25 | Merck & Co. Inc. | Tetrapeptide renin inhibitors having a novel c-terminal amino acid |
| JP3054738B2 (ja) * | 1988-07-22 | 2000-06-19 | 武田薬品工業株式会社 | チアゾロ［５，４―ｂ］アゼピン誘導体 |
| DK316989D0 (da) | 1989-06-26 | 1989-06-26 | Novo Nordisk As | Enzymer |
| US5430022A (en) * | 1990-05-14 | 1995-07-04 | Fujisawa Pharmaceutical Co., Ltd. | Peptide compound and its preparation |
| IT1247698B (it) * | 1990-06-21 | 1994-12-30 | Sigma Tau Ind Farmaceuti | 1-alchil-3-(acilammino)-e-caprolattami quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti |
| IT1254471B (it) * | 1992-02-27 | 1995-09-25 | Magis Farmaceutici | Derivati ammidici della (r)-glicerofosforil-(s)-serina o del suo diacil derivato, un processo per la loro preparazione e relative composizioni farmaceutiche per il potenziamento dei processi di apprendimento |
| US5821231A (en) * | 1993-12-06 | 1998-10-13 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using same |
| CN1081625C (zh) * | 1995-02-22 | 2002-03-27 | 诺瓦提斯公司 | 1－芳基－2－酰氨基乙烷化合物和它们作为神经激肽尤其是神经激肽1拮抗剂的用途 |
| SG64939A1 (en) * | 1995-07-17 | 2002-02-19 | Mitsui Chemicals Inc | Olefin polymerization catalyst, process for preparing olefin polymer, and olefin polymer |
| JP3633060B2 (ja) | 1995-09-22 | 2005-03-30 | Ｊｓｒ株式会社 | 低結晶性エチレン系ランダム共重合体およびその組成物 |
| US5817757A (en) * | 1995-10-30 | 1998-10-06 | Merck & Co., Inc. | Inhibitors of peptide binding to MHO class II proteins |
| ATE377006T1 (de) * | 1995-11-28 | 2007-11-15 | Cephalon Inc | Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer |
| MY132550A (en) * | 1996-08-22 | 2007-10-31 | Novartis Ag | Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists |
| GB9621836D0 (en) * | 1996-10-19 | 1996-12-11 | Zeneca Ltd | Peptide compounds |
| JP3812952B2 (ja) * | 1996-12-23 | 2006-08-23 | エラン ファーマシューティカルズ，インコーポレイテッド | シクロアルキル、ラクタム、ラクトンおよびその関連化合物およびその医薬組成物、並びに該化合物を用いたβ−アミロイドペプチドの放出および／またはその合成を阻害する方法 |
| US6989435B2 (en) | 1997-09-11 | 2006-01-24 | Cambridge University Technical Services Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
| US6506782B1 (en) * | 1998-02-27 | 2003-01-14 | Athena Neurosciences, Inc. | Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| ATE317691T1 (de) * | 1998-03-20 | 2006-03-15 | Daiichi Asubio Pharma Co Ltd | Benzochinonderivate enthaltende hemmer von nf-kb |
| US6395282B1 (en) | 1998-04-16 | 2002-05-28 | University Of Rochester | Immunogenic conjugates of Gram-negative bacterial autoinducer molecules |
| HRP990246A2 (en) * | 1998-08-07 | 2000-06-30 | Du Pont Pharm Co | Succinoylamino benzodiazepines as inhibitors of a beta protein production |
| US6117870A (en) * | 1998-11-12 | 2000-09-12 | Fujirebio Kabushiki Kaisha | Cyclic amide derivatives |
| HK1039784A1 (zh) | 1999-01-12 | 2002-05-10 | Cambridge Enterprise Limited | 抑制或增强炎症反應的化合物及方法 |
| US6344450B1 (en) * | 1999-02-09 | 2002-02-05 | Bristol-Myers Squibb Company | Lactam compounds and their use as inhibitors of serine proteases and method |
| WO2001068655A2 (en) * | 2000-03-10 | 2001-09-20 | Ariad Pharmaceuticals, Inc. | Caprolactam derivatives and uses thereof |
-
2004
- 2004-11-30 DK DK04798708.6T patent/DK1691814T3/da active
- 2004-11-30 EP EP10011516A patent/EP2279741A3/en not_active Withdrawn
- 2004-11-30 US US10/581,274 patent/US20080227724A1/en not_active Abandoned
- 2004-11-30 ES ES04798708T patent/ES2390272T3/es not_active Expired - Lifetime
- 2004-11-30 CN CN2013103149649A patent/CN103393691A/zh active Pending
- 2004-11-30 TW TW093136880A patent/TWI356821B/zh not_active IP Right Cessation
- 2004-11-30 PT PT04798708T patent/PT1691814E/pt unknown
- 2004-11-30 SI SI200431939T patent/SI1691814T1/sl unknown
- 2004-11-30 JP JP2006542002A patent/JP5248779B2/ja not_active Expired - Lifetime
- 2004-11-30 CA CA2547651A patent/CA2547651C/en not_active Expired - Fee Related
- 2004-11-30 EP EP04798708A patent/EP1691814B9/en not_active Expired - Lifetime
- 2004-11-30 PL PL04798708T patent/PL1691814T3/pl unknown
- 2004-11-30 WO PCT/GB2004/005030 patent/WO2005053702A2/en not_active Ceased
- 2004-11-30 KR KR1020067010733A patent/KR101228268B1/ko not_active Expired - Fee Related
- 2004-12-01 AR ARP040104477A patent/AR047730A1/es not_active Application Discontinuation
-
2006
- 2006-05-23 IL IL175857A patent/IL175857A0/en unknown
-
2012
- 2012-10-04 CY CY20121100921T patent/CY1113171T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7217701B2 (en) | Intracellular calcium concentration increase inhibitors | |
| EP2592066B1 (en) | Aminocarboxylic acid derivative and medical use thereof | |
| JP2007502264A5 (enExample) | ||
| JP2004516285A5 (enExample) | ||
| RU2008106058A (ru) | Производные пиридазинона в качестве агонистов рецептора тиреоидного гормона | |
| JP2006508107A5 (enExample) | ||
| JP2005526696A5 (enExample) | ||
| HUE032113T2 (en) | Methylphenidate-prodrugs, processes of making and using the same | |
| JP2007512387A5 (enExample) | ||
| JP2005500312A5 (enExample) | ||
| RU2004137279A (ru) | Производные дифенилазетидинона для лечения нарушений метаболизма липидов | |
| JP2008509187A5 (enExample) | ||
| CA2206794A1 (fr) | Nouveaux derives de 3,5-dioxo-(2h,4h)-1,2,4-triazines, leur preparation et leur application a titre de medicament | |
| RU2007101653A (ru) | Производные 1-азабицикло[3.3.1]нонанов | |
| JP5423905B2 (ja) | 新規化合物及びその医薬用途 | |
| JP2002527474A5 (ja) | 躁病および双極性障害の治療のための医薬 | |
| PT2420491E (pt) | Compostos de piperidina 3,5-substituída como inibidores de renina | |
| JP2016537353A (ja) | 脂肪酸ナイアシン複合体 | |
| JP2014504648A5 (enExample) | ||
| JP2008509210A5 (enExample) | ||
| JP2008542386A5 (enExample) | ||
| JP2008543821A5 (enExample) | ||
| EP1174131A1 (en) | Agent for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient | |
| RU2006123438A (ru) | Противовоспалительные средства | |
| RU2001121989A (ru) | Производные (1-фенацил-3-фенил-3-пиперидилэтил)пиперидина, способы их получения и содержащие их фармацевтические композиции |